Xtant Medical
About Xtant Medical
Xtant Medical, a medical company, manufactures, markets, and develops regenerative medicine products and medical devices for international and domestic markets. Bacterin International and X-spine Systems have combined to form XTANT Medical (NYSE MKT: XTNT), a comprehensive supplier of orthopedic and spine surgery products. Pairing the orthobiologics line-up of Bacterin with the hardware suite of X-spine, the union creates an extensive portfolio of complementary products that serve the needs of the orthopedic and neurosurgery markets, with minimal overlap. The combined company has an expanded national footprint of over 300 field sales representatives and more than 50 national accounts and regional health systems/IDN contracts, positioning XTANT Medical as a strong competitor in the spine surgery marketplace. With both Bacterin and X-spine operating units healthy and thriving, the resulting synergy increases the potential for accelerated growth and market penetration. Xtant Medical was founded in 2015 and is headquartered in Montana, USA.
Company Metrics
- Employees: 101-250
- Monthly Visits: None
- Tech Stack: 18 active products
Financial Information
- Estimated Revenue: $10M to $50M
- Total Funding: 176643658 USD
- Last Funding: 9750000 USD (Post-IPO Equity)
- Funding Status: IPO
Technology Stack
Xtant Medical actively uses 18 products in their tech stack.
Market Presence
Industries: Health Care, Manufacturing, Medical, Medical Device
Headquarters: Belgrade, Montana, United States
Leadership
- Sean Browne - President, CEO LinkedIn
Employees
- Kevin Brandt - Chief Commercial Officer (LinkedIn)
- Mark Schallenberger - Chief Operations Officer (LinkedIn)
- Scott Neils - Chief Financial Officer (LinkedIn)